Anmelden
  1. Home
  2. Alle Unternehmen
  3. Bristol-Myers Squibb Company
  4. Kennzahlen
  5. DSO
Bristol-Myers Squibb Company logo
Bristol-Myers Squibb Company BMY
€ 57.46 0.64%
report update icon

Quartalsbericht 2026-Q2
hinzugefügt 30.07.2026

Bristol-Myers Squibb Company DSO | BMY

DSO Jährlich Bristol-Myers Squibb Company

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006
83.9 81.9 84.4 76.1 70.3 69.5 107 96.5 111 104 94.8 77.9 74.8 63.9 64.3 - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
111 63.9 84

DSO Vierteljährlich Bristol-Myers Squibb Company

2026-Q2 2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1 2010-Q3 2010-Q2 2010-Q1 2009-Q3 2009-Q2
70.1 82.6 85.2 82.6 88.9 86.1 81.8 79.8 84.9 82 80.2 - 39.1 32.7 70 - 71.7 68.9 70.7 70.1 73.6 76.6 68.5 88.3 117 112 104 89.5 95.6 95.4 108 106 109 112 110 96.5 103 104 102 91.5 96.4 94.2 86.8 72.7 78.9 79.5 80.8 69 75.4 75.7 76.7 67.1 75.3 63.3 59.3 62.6 63.9 62.9 64 - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
117 32.7 82.3

DSO anderer Aktien in der Pharmaeinzelhändler

Name DSO Preis % 24h Marktkapitalisierung Land
Фармсинтез Фармсинтез
LIFE
 		209 - - - russiaRussia
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		2.75 K - -1.52 % $ 24.7 M usaUSA
Cleveland BioLabs, Inc. Cleveland BioLabs, Inc.
CBLI
 		16 - -7.31 % $ 49 M usaUSA
Five Prime Therapeutics, Inc. Five Prime Therapeutics, Inc.
FPRX
 		2.35 - - $ 1.77 B usaUSA
Aravive Aravive
ARAV
 		16.8 - -13.39 % $ 1.45 M usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
 		8.16 K - -6.81 % $ 3.04 B usaUSA
Biofrontera AG Biofrontera AG
BFRA
 		42.2 - -8.24 % $ 105 M germanyGermany
China Biologic Products Holdings, Inc. China Biologic Products Holdings, Inc.
CBPO
 		106 - 1.68 % $ 4.65 B chinaChina
Flexion Therapeutics, Inc. Flexion Therapeutics, Inc.
FLXN
 		129 - - $ 459 M usaUSA
Heat Biologics, Inc. Heat Biologics, Inc.
HTBX
 		21.9 - -5.76 % $ 99.8 M usaUSA
Kindred Biosciences, Inc. Kindred Biosciences, Inc.
KIN
 		5.4 - 0.11 % $ 419 M usaUSA
Shineco, Inc. Shineco, Inc.
TYHT
 		172 - -3.90 % $ 97.2 M chinaChina
Progenity, Inc. Progenity, Inc.
PROG
 		62.3 - -3.47 % $ 164 M usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
 		52.1 - - $ 1.2 B usaUSA
Strongbridge Biopharma plc Strongbridge Biopharma plc
SBBP
 		33.3 - 1.52 % $ 136 M usaUSA
Seneca Biopharma, Inc. Seneca Biopharma, Inc.
SNCA
 		499 - -1.19 % $ 28.7 M usaUSA
IVERIC bio IVERIC bio
ISEE
 		2.41 - - $ 5.51 B usaUSA
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
 		21.2 - -0.04 % $ 2.62 B usaUSA
Celsion Corporation Celsion Corporation
CLSN
 		15.6 - -6.63 % $ 13.9 M usaUSA
I-Mab I-Mab
IMAB
 		271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		84.7 - - $ 40.3 B usaUSA
AnaptysBio AnaptysBio
ANAB
 		58 $ 56.8 0.94 % $ 1.63 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
 		13.6 - - $ 867 M germanyGermany
Midatech Pharma plc Midatech Pharma plc
MTP
 		204 - -18.52 % $ 27.3 M britainBritain
Affimed N.V. Affimed N.V.
AFMD
 		31.4 - -34.95 % $ 21.5 M germanyGermany
AnPac Bio-Medical Science Co., Ltd. AnPac Bio-Medical Science Co., Ltd.
ANPC
 		118 - -1.58 % $ 28.1 M chinaChina
Celyad Oncology SA Celyad Oncology SA
CYAD
 		64.4 - - $ 12.5 M belgiumBelgium
Galapagos NV Galapagos NV
GLPG
 		56.5 - - $ 1.83 B belgiumBelgium
Teligent, Inc. Teligent, Inc.
TLGT
 		90.7 - -13.85 % $ 16.1 M usaUSA
Viela Bio, Inc. Viela Bio, Inc.
VIE
 		169 - - $ 2.91 B usaUSA
Aphria Inc. Aphria Inc.
APHA
 		55.2 - -0.45 % $ 4.87 B canadaCanada